Expression of TAP73 and ΔNP73 in malignant gliomas

Oncology Reports

Volumn 11, Issue 6, 2004, Pages 1337-1341

  Ugur, Hasan ^a,b   Sayan, A Emre ^a   Ozdamar, Sukru O ^c   Kanpolat, Yucel ^b   Ozturk, Mehmet ^a  

^a BILKENT UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Brain tumor; Dominant negative p73; Glial tumor; p73; Retinoblastoma pathway; Transcriptionally active p73; Tumor progression

Indexed keywords

DNA BINDING PROTEIN; NUCLEAR PROTEIN; RNA; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ARTICLE; BRAIN; COMPARATIVE STUDY; DOMINANT GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; HUMAN; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

BRAIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; GENES, TUMOR SUPPRESSOR; GLIOMA; HUMANS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 16544372469     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.6.1337     Document Type: Article

References (32)

1. Vandenberg SR: Current diagnostic concepts of astrocytic tumors. J Neuropathol Exp Neurol 51: 644-657, 1992.
2. Kleihues P, Louis DN, Scheithauer BW, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215-225, 2002. (Pubitemid 34212595)
3. Salcman MS, Scholtz H, Kaplan RS and Kulic S: Long-term survival in patients with malignant astrocytoma. Neurosurgery 34: 213-220, 1994. (Pubitemid 24044097)
4. Sasaki M and Plate KH: Gene therapy of malignant glioma: recent advances in experimental and clinical studies. Ann Oncol 9: 1155-1166, 1998. (Pubitemid 28552803)
5. Levine AJ, Chang A, Dittmer D, Notterman DA, Silver A, Thorn K, Welsh D and Wu M: The p53 tumor suppressor gene. J Lab Clin Med 123: 817-823, 1994. (Pubitemid 2103596)
6. Malkin D: p53 and the Li-Fraumeni syndrome. Cancer Genet Cytogenet 66: 83-92, 1993.
7. Fueyo J, Gomez-Manzano C, Yung WK and Kyritsis AP: The functional role of tumor suppressor genes in gliomas: clues for future therapeutic strategies. Neurology 51: 1250-1255, 1998. (Pubitemid 28520539)
8. Nieder C, Petersen S, Petersen C and Thames HD: The challenge of p53 as prognostic and predictive factor in gliomas. Cancer Treat Rev 26: 67-73, 2000. (Pubitemid 30102801)
9. Kaghad M, Bonnet H, Yang A, et al: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819, 1997. (Pubitemid 27357971)
10. Stiewe T and Putzer BM: Role of p73 in malignancy: tumor suppressor or oncogene? Cell Death Differ 9: 237-245, 2002. (Pubitemid 34223867)
11. Melino G, De Laurenzi V and Vousden KH: p73: friend or foe in tumorigenesis. Nat Rev Cancer 2: 605-615, 2002. (Pubitemid 37328927)
12. Zaika AI, Kovalev S, Marchenko ND and Moll UM: Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res 59: 3257-3263, 1999. (Pubitemid 29316031)
13. Stiewe T, Theseling CC and Putzer BM: Transactivation-deficient Delta TAp73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. J Biol Chem 277: 14177-14185, 2002. (Pubitemid 34968030)
14. De Laurenzi V, Costanzo A, Barcaroli D, et al: Two new p73 splice variants, gamma and delta, with different transcriptional activity. J Exp Med 188: 1763-1768, 1998. (Pubitemid 28516121)
15. Sayan AE, Sayan BS, Findikli N and Ozturk M: Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells. Oncogene 20: 5111-5117, 2001. (Pubitemid 32844039)
16. Grob TJ, Novak U, Maisse C, et al: Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 8: 1213-1223, 2001.
17. Yang A, Walker N, Bronson R, et al: p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404: 99-103, 2000. (Pubitemid 30143141)
18. Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR and Miller FD: An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 289: 304-306, 2000. (Pubitemid 30469909)
19. Zaika AI, Slade N, Erster SH, et al: DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 196: 765-780, 2002.
20. Maris JM and Matthay KK: Molecular biology of neuroblastoma. J Clin Oncol 17: 2264-2279, 1999. (Pubitemid 29318861)
21. Casciano I, Mazzocco K, Boni L, et al: Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ 9: 246-251, 2002. (Pubitemid 34223868)
22. Douc-Rasy S, Barrois M, Echeynne M, et al: DeltaN-p73alpha accumulates in human neuroblastic tumors. Am J Pathol 160: 631-639, 2002. (Pubitemid 34160341)
23. Fillippovich I, Sorokina N, Gatei M, et al: Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. Oncogene 20: 514-522, 2001. (Pubitemid 32158231)
24. Loiseau H, Arsaut J and Demotes-Mainard J: p73 gene transcripts in human brain tumors: overexpression and altered splicing in ependymomas. Neurosci Lett 263: 173-176, 1999. (Pubitemid 29158956)
25. Dong S, Pang JC, Hu J, Zhou LF and Ng HK: Transcriptional inactivation of TP73 expression in oligodendroglial tumors. Int J Cancer 98: 370-375, 2002. (Pubitemid 34188680)
26. Kamiya M and Nakazato Y: The expression of p73, p21 and MDM2 proteins in gliomas. J Neurooncol 59: 143-149, 2002. (Pubitemid 35021562)
27. Maher EA, Furnari FB, Bachoo RM, et al: Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311-1333, 2001. (Pubitemid 32524640)
28. Muller H and Helin K: The E2F transcription factors: key regulators of cell proliferation. Biochim Biophys Acta 1470: M1-M12, 2000. (Pubitemid 30070163)
29. Stiewe T and Putzer BM: Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet 26: 464-469, 2000.
30. Bergamaschi D, Gasco M, Hiller L, et al: p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell 3: 387-402, 2003. (Pubitemid 38340307)
31. Fueyo J, Alemany R, Gomez-Manzano C, et al: Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J Natl Cancer Inst 95: 652-660, 2003. (Pubitemid 36603721)
32. Gong JG, Costanzo A, Yang HQ, et al: The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399: 806-809, 1999. (Pubitemid 29293179)